Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OZURDEX for Diabetic Macular Edema After Cataract Surgery
NCT01748487Phase 3Completed
- Sponsor
- University Health Network
- Start
- Dec 2012
- Primary completion
- Sep 2015
- Modality
- Implantable Devices, Implantable Hydrogels, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ozurdex in diabetic macular edema (DME), sponsored by University Health Network. Started Dec 2012; status: completed.
02
Drugs
ozurdex
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT01748487.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01748487.